Madrigal Pharmaceuticals
Price & Volume
Stats
See more52W Range | $189-$368.29 |
Market Cap | $7.2B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $76.8M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $74M |
Diluted EPS | -$25.02 |
News
See moreYahoo Finance • yesterday
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2024 Financial Results and Host Webcast on February 26, 2025
Yahoo Finance • 5 months ago
Is Madrigal Pharmaceuticals, Inc. (MDGL) the Best Guru Stock To Buy Now?
Yahoo Finance • 8 months ago
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
Yahoo Finance • 10 months ago
Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024
About
CEO | Mr. William J. Sibold |
CFO | Ms. Mardi C. Dier |
Address | Four Tower Bridge, West Conshohocken, PA, United States, 19428 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 376 |
